Stock listing
889627 Stock Price, News, Filings & Events — Jcr Pharmaceuticals Co., Ltd.
Selected listing: 889627 · LS · EUR · DE
This page tracks Jcr Pharmaceuticals Co., Ltd.'s 889627:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 889627:LS. 889627:LS is the stock-level entry point for investors researching Jcr Pharmaceuticals Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jcr Pharmaceuticals Co., Ltd. (4552) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

- Ticker
- 889627:LS
- Asset type
- Stock
- Market cap
- $417.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Jcr Pharmaceuticals Co., Ltd. 889627:LS stock context
This page tracks Jcr Pharmaceuticals Co., Ltd.'s 889627:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 889627:LS. 889627:LS is the stock-level entry point for investors researching Jcr Pharmaceuticals Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jcr Pharmaceuticals Co., Ltd. (4552) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Jcr Pharmaceuticals Co., Ltd.
FY2026 First Quarter Results Briefing Session Material
July 30, 2026
JCR Pharmaceuticals - Notice Regarding the Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation
July 23, 2026
Notice Regarding the Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation
July 22, 2026
JCR Pharmaceuticals Announces Development Plan in Japan for Givinostat for Duchenne Muscular Dystrophy
July 14, 2026
Matters Concerning Controlling Shareholders (Affiliated Companies)
June 23, 2026
Research Jcr Pharmaceuticals Co., Ltd.
Jcr Pharmaceuticals Co., Ltd. investor report
Review AI stock analysis and investor report context for 889627:LS.
Jcr Pharmaceuticals Co., Ltd. company profile
View the public company page for Jcr Pharmaceuticals Co., Ltd. on 6ix.
Jcr Pharmaceuticals Co., Ltd. news
Read company news and market updates connected to Jcr Pharmaceuticals Co., Ltd..
Jcr Pharmaceuticals Co., Ltd. investor events
Find investor webinars, events, and replay context for Jcr Pharmaceuticals Co., Ltd..
Alternate listings
4552:TSE
JP · JPY
Alternate listing for Jcr Pharmaceuticals Co., Ltd.; the primary context on this page is 889627:LS.
JCR:FWB
DE · EUR
Alternate listing for Jcr Pharmaceuticals Co., Ltd.; the primary context on this page is 889627:LS.
889627:LSX
DE · EUR
Alternate listing for Jcr Pharmaceuticals Co., Ltd.; the primary context on this page is 889627:LS.
JCRRF:OTC
US · USD
Alternate listing for Jcr Pharmaceuticals Co., Ltd.; the primary context on this page is 889627:LS.